Data on long-term safety and efficacy of ticagrelor in patients with stable coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) undergoing percutaneous coronary intervention (PCI) are limited. This… Click to show full abstract
Data on long-term safety and efficacy of ticagrelor in patients with stable coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) undergoing percutaneous coronary intervention (PCI) are limited. This is a post-hoc analysis of the safety and efficacy of ticagrelor among
               
Click one of the above tabs to view related content.